Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

K. M. Tewey, T. C. Rowe, L. Yang, B. D. Halligan, Leroy-Fong Liu

Research output: Contribution to journalArticle

1145 Citations (Scopus)

Abstract

Adriamycin (doxorubicin), a potent antitumor drug in clinical use, interacts with nucleic acids and cell membranes, but the molecular basis for its antitumor activity is unknown. Similar to a number of intercalative antitumor drugs and nonintercalative epipodophyllotoxins (VP-16 and VM-26), adriamycin has been shown to induce single- and double-strand breaks in DNA. These strand breaks are unusual because a cavalently bound protein appears to be associated with each broken phosphodiester bond. In studies in vitro, mammalian DNA topoisomerase II mediates DNA damage by adriamycin and other related antitumor drugs.

Original languageEnglish
Pages (from-to)466-468
Number of pages3
JournalScience
Volume226
Issue number4673
Publication statusPublished - 1984
Externally publishedYes

Fingerprint

Type II DNA Topoisomerase
Doxorubicin
DNA Damage
Antineoplastic Agents
Teniposide
Podophyllotoxin
Double-Stranded DNA Breaks
Etoposide
Nucleic Acids
Cell Membrane
doxorubicin-DNA
Proteins

ASJC Scopus subject areas

  • General

Cite this

Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L-F. (1984). Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science, 226(4673), 466-468.

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. / Tewey, K. M.; Rowe, T. C.; Yang, L.; Halligan, B. D.; Liu, Leroy-Fong.

In: Science, Vol. 226, No. 4673, 1984, p. 466-468.

Research output: Contribution to journalArticle

Tewey, KM, Rowe, TC, Yang, L, Halligan, BD & Liu, L-F 1984, 'Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II', Science, vol. 226, no. 4673, pp. 466-468.
Tewey KM, Rowe TC, Yang L, Halligan BD, Liu L-F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984;226(4673):466-468.
Tewey, K. M. ; Rowe, T. C. ; Yang, L. ; Halligan, B. D. ; Liu, Leroy-Fong. / Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. In: Science. 1984 ; Vol. 226, No. 4673. pp. 466-468.
@article{cc978fddff5845dea6bfdb4e5460fe3e,
title = "Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II",
abstract = "Adriamycin (doxorubicin), a potent antitumor drug in clinical use, interacts with nucleic acids and cell membranes, but the molecular basis for its antitumor activity is unknown. Similar to a number of intercalative antitumor drugs and nonintercalative epipodophyllotoxins (VP-16 and VM-26), adriamycin has been shown to induce single- and double-strand breaks in DNA. These strand breaks are unusual because a cavalently bound protein appears to be associated with each broken phosphodiester bond. In studies in vitro, mammalian DNA topoisomerase II mediates DNA damage by adriamycin and other related antitumor drugs.",
author = "Tewey, {K. M.} and Rowe, {T. C.} and L. Yang and Halligan, {B. D.} and Leroy-Fong Liu",
year = "1984",
language = "English",
volume = "226",
pages = "466--468",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "4673",

}

TY - JOUR

T1 - Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

AU - Tewey, K. M.

AU - Rowe, T. C.

AU - Yang, L.

AU - Halligan, B. D.

AU - Liu, Leroy-Fong

PY - 1984

Y1 - 1984

N2 - Adriamycin (doxorubicin), a potent antitumor drug in clinical use, interacts with nucleic acids and cell membranes, but the molecular basis for its antitumor activity is unknown. Similar to a number of intercalative antitumor drugs and nonintercalative epipodophyllotoxins (VP-16 and VM-26), adriamycin has been shown to induce single- and double-strand breaks in DNA. These strand breaks are unusual because a cavalently bound protein appears to be associated with each broken phosphodiester bond. In studies in vitro, mammalian DNA topoisomerase II mediates DNA damage by adriamycin and other related antitumor drugs.

AB - Adriamycin (doxorubicin), a potent antitumor drug in clinical use, interacts with nucleic acids and cell membranes, but the molecular basis for its antitumor activity is unknown. Similar to a number of intercalative antitumor drugs and nonintercalative epipodophyllotoxins (VP-16 and VM-26), adriamycin has been shown to induce single- and double-strand breaks in DNA. These strand breaks are unusual because a cavalently bound protein appears to be associated with each broken phosphodiester bond. In studies in vitro, mammalian DNA topoisomerase II mediates DNA damage by adriamycin and other related antitumor drugs.

UR - http://www.scopus.com/inward/record.url?scp=0021151237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021151237&partnerID=8YFLogxK

M3 - Article

VL - 226

SP - 466

EP - 468

JO - Science

JF - Science

SN - 0036-8075

IS - 4673

ER -